Who owns an AI generated invention or work or art?

The question captures our attention. In the midst of the fourth industrial revolution this is a question that was long overdue. This revolution is marked by the emergence of new technologies including: robotics,…

Llegir més
Brazil’s ANVISA will stop examining pharmaceutical patent applications

Twenty-two years after the approval of the Brazilian Patent Law (Law 9.279/96), the obligation (article 229-C) for all pharmaceutical patents to be subject to prior approval by ANVISA (National Health Surveillance Agency, equivalent…

Llegir més
IP protection in the cosmetics sector: patents, utility models or trade secrets?

When we talk about cosmetics, we inevitably talk about formulas, processes or procedures embodied in certain products that help us to care for, improve and beautify aspects of our skin. Nowadays, there are…

Llegir més
What is a Protected Designation of Origin (PDO)? Concept and requirements for obtaining it

When it comes to agricultural products and foodstuffs, there are many advantages that a designation of origin can offer them. However, these products must meet a series of requirements in order to obtain…

Llegir més
New guidelines for the examination of patent applications in the field of biotechnology in Brazil

On 1 December 2020, INPI/PR Normative Instruction No. 118/2020 was published in the Industrial Property Journal (RPI) and came into force, which establishes the new Guidelines for the Examination of Patent Applications in…

Llegir més
The amendment before the EPO of a patent subject to ongoing litigation

On October 16, 2020, the Provincial Court of Barcelona issued a ruling that we consider very interesting and which provides an answer to the question of what should happen in an ongoing dispute…

Llegir més
The new Federal Law on the Protection of Industrial Property enters into force in Mexico

On November 5th, 2020, in view of the entry into force of the #USMCA, #ACEUM, (July 1, 2020) and the #HagueAgreement (June 6, 2020), Mexico launches its new FEDERAL LAW FOR THE PROTECTION…

Llegir més
Intervention as “amicus curiae” before the Courts of Argentina in patent litigation.

The Argentinian Federal Court has recently confirmed that a third party may not be entitled to intervene as third party at a Court level. In Actelion Pharmaceuticals v. the Patent Office of Argentina,…

Llegir més
Recent News and a reminder regarding patent prosecution in Brazil

This month of September/2020 has started with news from the Brazilian Patent and Trademark Office as regards to patents. Priority Examination Two additional priority examinations have been allowed as of September 1st which…

Llegir més